Founding member of a veterinary oncology company, moved into an advisory role in 2020 after disrupting the marketplace. Introduced new modalities into the oncology treatment lifecycle and gave families hope (and pets a new lease on life). Took the company from $0 to $17M in annual revenue and positioned Petcure for acquisition in 2021 at a 12X multiple. Orchestrated growth with the strategic placement of clinics, blanketing the US, and introducing new access to care. Differentiated Petcure’s level of care as the 1st company to transition stereotactic radiosurgery (SRS) from humans to veterinary medicine. Clearly articulated this core distinction and wove this new approach into the branding, beginning with the name Petcure. Set a new standard in patient satisfaction, crushing industry standards and delivering an NPS averaging 25 points higher (low 90s) than competitors. With no margin for error, baked empathy, responsiveness, and capability into the Petcure’s DNA.

Accepted consulting engagements, stepping in as fractional CSO and CMO of companies seeking guidance. Served as trusted advisor to boards and CEOs, always with a focus on stabilizing operations and establishing a roadmap to success. Rebuilt operating models, adding millions in new revenue to clients and frequently reshaping how they did business. Achieved huge success as a disruptor, turning at least one client into a household name. Overhauled media planning and marketing strategy of a floundering dental healthcare company with clinics across the US. Improved branded communications and creative execution, taking the company from $100M in 2010 to $715M in 2016. Engaged by Northwestern Medicine in Chicago as an expert in integrated healthcare within oncology. Evolved their value proposition related to cancer care and encouraged integration of acupuncture, massage therapy, nutritional counseling, and support groups into the treatment lifecycle.

Oversaw all branding, communication, and direct response initiatives for a very fast growing company. Part of a strategic team which developed one of the fastest growing cancer treatment organizations in the country.

Head of US expansion. Led a team of 20 employees and directed an explosive 5-year growth trajectory, beginning with identifying new markets and spearheading regional marketing campaigns and digital marketing strategy. Found demand in secondary and tertiary markets, opening limited-service hotels (60 rooms, indoor pool) every 10 days for a period of 2 ½ years. Took the company public (IPO) on the NASDAQ Exchange in 1998 and established a solid foundation for growth, one that led to acquisition by Wyndham in 2005 for $3.2B.

Led marketing strategy for the most exclusive hotel association in the world, all luxury destinations. Overcame the challenge of building a unified membership spread from Hong Kong to Prague, Paris, and Los Angeles. Flipped customer acquisition strategy with a unified message, increasing members by 2X from 100 to 200 world-class luxury hotels. Utilized a new level of cross-cultural finesse and high emotional intelligence to build a true consensus, shifting the organization with new clarity, sophistication, and results-driven benchmarks.

Grew up with a young company, working directly for founder Isadore Sharp. Played a key role in establishing the Four Seasons brand in multiple markets across the US and building one of the greatest brands in the world. Directed new hotel development worldwide (domestic and overseas), achieving growth objectives others said could not be done. Built the Four Seasons on Michigan Ave. in Chicago, opening at full capacity on day one despite being across the street from another Four Seasons property (The Ritz Carlton). Eventually led all of field marketing for the US and Europe, building a talented team of employees.